Tumor secretion of CCL22 activates intratumoral Treg infiltration and is independent prognostic predictor of breast cancer.
about
Exploiting the Immunomodulatory Properties of Chemotherapeutic Drugs to Improve the Success of Cancer ImmunotherapyImmunosuppressive Mechanisms of Malignant Gliomas: Parallels at Non-CNS SitesTwo faces of TGF-beta1 in breast cancer.SCRG1 suppresses LPS-induced CCL22 production through ERK1/2 activation in mouse macrophage Raw264.7 cellsSystemic CD8+ T cell-mediated tumoricidal effects by intratumoral treatment of oncolytic herpes simplex virus with the agonistic monoclonal antibody for murine glucocorticoid-induced tumor necrosis factor receptor.Islet cell transplant and the incorporation of Tregs.The redox biology network in cancer pathophysiology and therapeuticsMacrophage-derived chemokine CCL22 and regulatory T cells in ovarian cancer patientsFucoidan inhibits CCL22 production through NF-κB pathway in M2 macrophages: a potential therapeutic strategy for cancer.Negative immune factors might predominate local tumor immune status and promote carcinogenesis in cervical carcinoma.CTLA-4 positive breast cancer cells suppress dendritic cells maturation and function.The potential to target CCL5/CCR5 in breast cancer.The correlation of CD19 + CD24 + CD38 + B cells and other clinicopathological variables with the proportion of circulating Tregs in breast cancer patients.Characterization of the Protective Role of Regulatory T Cells in Experimental Periapical Lesion Development and Their Chemoattraction Manipulation as a Therapeutic Tool.The prognostic value of regulatory T cells infiltration in HER2-enriched breast cancer microenvironment.Similarities and differences between helminth parasites and cancer cell lines in shaping human monocytes: Insights into parallel mechanisms of immune evasion.Targeting the Immune Microenvironment in Acute Myeloid Leukemia: A Focus on T Cell Immunity.
P2860
Q26779184-F8306618-710D-4DE1-8E14-B68A34A00E80Q26798402-D842EF3F-1B8E-422D-BE04-B05D7F951EF6Q33661529-4459DDBD-095B-4C88-892D-946A943EC542Q33702432-3F581298-EEB1-4A0D-8D25-8E799C9AD588Q34020594-50777C77-3389-4807-8D19-E93E5A1C3335Q34729072-0210D1ED-FD83-481A-B65E-B5D084610A90Q35849711-FE24AFAC-7395-4F9E-ABFF-83BDBC70411AQ35929374-495E3E96-164D-4D26-9222-B2527150920DQ37360097-91B62794-BB17-4100-AB68-05D5D7CADF5CQ37586829-E90426CF-EFEF-4277-994D-AA73C8926168Q37706688-BAEC8703-7385-42AD-A145-DD0E71EB883DQ38254356-22295ED9-E049-4B30-B325-4017E9937DE0Q38827388-5D9C5EEB-F405-4686-9D8D-D3FE81C38E41Q42663025-418048F9-33FA-4B16-B2A5-E9A34A537316Q48093934-49222095-5CF6-476F-AEC4-8A5AAEC2B1ACQ54233279-E5621723-7185-4583-B78C-9A20BF98460CQ55299267-561C08B0-BA79-44B8-BC9B-A8925A81E43E
P2860
Tumor secretion of CCL22 activates intratumoral Treg infiltration and is independent prognostic predictor of breast cancer.
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Tumor secretion of CCL22 activ ...... ic predictor of breast cancer.
@ast
Tumor secretion of CCL22 activ ...... ic predictor of breast cancer.
@en
type
label
Tumor secretion of CCL22 activ ...... ic predictor of breast cancer.
@ast
Tumor secretion of CCL22 activ ...... ic predictor of breast cancer.
@en
prefLabel
Tumor secretion of CCL22 activ ...... ic predictor of breast cancer.
@ast
Tumor secretion of CCL22 activ ...... ic predictor of breast cancer.
@en
P2093
P2860
P1433
P1476
Tumor secretion of CCL22 activ ...... ic predictor of breast cancer.
@en
P2093
Fang-Fang Liu
Mei-Jing Ren
Xiao-Jing Guo
Xin-Min Zhang
Ya-Qing Li
P2860
P304
P356
10.1371/JOURNAL.PONE.0076379
P407
P577
2013-10-04T00:00:00Z